White Matter by Diffusion MRI Following Methylphenidate Treatment: A Randomized Control Trial in Males with Attention-Deficit/Hyperactivity Disorder.
Adult
Age Factors
Attention Deficit Disorder with Hyperactivity
/ drug therapy
Central Nervous System Stimulants
/ pharmacology
Child
Diffusion Magnetic Resonance Imaging
/ methods
Double-Blind Method
Humans
Male
Methylphenidate
/ pharmacology
Netherlands
Prospective Studies
White Matter
/ drug effects
Young Adult
Journal
Radiology
ISSN: 1527-1315
Titre abrégé: Radiology
Pays: United States
ID NLM: 0401260
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
pubmed:
14
8
2019
medline:
11
3
2020
entrez:
14
8
2019
Statut:
ppublish
Résumé
BackgroundMethylphenidate (MPH) is highly effective in treating attention-deficit/hyperactivity disorder (ADHD). However, not much is known about its effect on the development of human brain white matter (WM).PurposeTo determine whether MPH modulates WM microstructure in an age-dependent fashion in a randomized double-blind placebo-controlled trial (Effects of Psychotropic Medication on Brain Development-Methylphenidate, or ePOD-MPH) among ADHD referral centers between October 13, 2011, and June 15, 2015, by using diffusion-tensor imaging (DTI).Materials and MethodsIn this prospective study (NTR3103 and NL34509.000.10), 50 stimulant treatment-naive boys and 49 young adult men diagnosed with ADHD (all types) according to
Identifiants
pubmed: 31407970
doi: 10.1148/radiol.2019182528
doi:
Substances chimiques
Central Nervous System Stimulants
0
Methylphenidate
207ZZ9QZ49
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM